Home›People›John Alam
JA

John Alam

CEO & President, director at CervoMed. Also CEO and director at EIP Pharma.

ExecutiveDirectorPublic company
Updated Oct 27, 2026·Latest SEC filing Jun 10, 2026·Suggest an edit

About John Alam

John Alam is CEO & President, director at CervoMed.

Form D filings name John Alam as CEO and director at EIP Pharma.

John Alam reports to the SEC as a director, officer or major shareholder of 3 public companies, including Pathfinder Cell Therapy (PFND) and Vertex Pharmaceuticals Inc. / Ma (VRTX).

John Alam first appears on SEC filings in 2006.

Experience

This experience comes from SEC filings. The years are when the filings name John Alam in the role, so the role may have started earlier or lasted longer.

CervoMed Inc.
CEO & President, director
2023 – 2026 · Public company (CRVO)
EIP Pharma, Inc.
CEO and director
2018 – 2023 · Boston, MA
Pathfinder Cell Therapy, Inc.
Director
2011 · Public company (PFND)
Vertex Pharmaceuticals Inc. / Ma
EVP, Med. Dev. Group & CMO
2006 – 2008 · Public company (VRTX)

Key Colleagues at Startups

The people John Alam works with at each company, as listed on that company's latest Form D.

EIP Pharma, Inc. · Form D, Jul 20, 2023
JP
Jeff Poulton
Director
WT
William Turner
Executive officer
SG
FZ
Frank Zavrl
Director
KB
Kelly Blackburn
Executive officer
MS

Sources

  1. SECEIP Pharma, Inc. Form D, filed Jul 20, 2023
  2. SECForms 3, 4 and 5 filed by John Alam (SEC filer 1197014)